Alefacept: where it stands todayJinan Chaarani
Department of Dermatology, Mount Sinai School of Medicine, 5 East 98th Street, NY 10029, USA
Expert Opin Drug Metab Toxicol 6:355-61. 2010
..It selectively reduces CD45RO(+) memory T cells and inhibits T-cell activation. Clinical data support its safety and efficacy in a substantial subset of patients with psoriasis...
Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trialsMark Lebwohl
Mount Sinai School of Medicine, New York City, New York 10029, USA
J Am Acad Dermatol 66:731-41. 2012
..Ustekinumab targets interleukin (IL)-12 and IL-23 in the treatment of moderate-to-severe psoriasis...
Psoriasis treatment: traditional therapyM Lebwohl
The Mount Sinai School of Medicine, New York, NY, USA
Ann Rheum Dis 64:ii83-6. 2005
..Systemic therapies such as methotrexate, retinoids, and ciclosporin are effective for patients with refractory or extensive cutaneous disease...
Topical calcitriol is degraded by ultraviolet lightMark Lebwohl
Department of Dermatology, The Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
J Invest Dermatol 121:594-5. 2003
..Calcipotriene, the only vitamin D analog already approved for psoriasis in the USA, has been used successfully in combination with ultraviolet B and psoralen plus ultraviolet A...
Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasisMark Lebwohl
Mount Sinai School of Medicine, New York, NY 10029, USA
Cutis 83:205-12. 2009
..Clinical improvement was maintained for up to 52 weeks, with no clinical effect on calcium homeostasis or other relevant laboratory test parameters...
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasisMark Lebwohl
Mount Sinai School of Medicine, New York, NY 10029, USA
Arch Dermatol 139:719-27. 2003
....
Innovations in the treatment of psoriasisMark Lebwohl
Department of Dermatology, The Mount Sinai School of Medicine, New York, NY 10029, USA
J Am Acad Dermatol 51:S40-1. 2004
No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 yearsMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA
Arch Dermatol 141:861-4. 2005
..To determine the incidence of cutaneous squamous cell carcinoma (SCC) in patients with rheumatoid arthritis receiving etanercept, a tumor necrosis factor antagonist, for up to 5 years...
Proven efficacy of tacrolimus for facial and intertriginous psoriasisMark Lebwohl
Arch Dermatol 141:1154. 2005
Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York, New York 10029 6574, USA
J Am Acad Dermatol 50:714-21. 2004
..The immune system plays a critical role in the development and pathogenesis of actinic keratosis (AK). Imiquimod has been shown to stimulate the cutaneous immune response and be effective for the treatment of nonmelanoma skin cancers...
New roles for systemic retinoidsMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA
J Drugs Dermatol 5:406-9. 2006
....
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendationsMark Lebwohl
Mount Sinai School of Medicine, New York, New York 10029, USA
J Am Acad Dermatol 63:571-9. 2010
..Patients with psoriasis tend to be overweight, and the efficacy of fixed-dose biologics may be compromised by high body weight...
A clinician's paradigm in the treatment of psoriasisMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York, New York 10029, USA
J Am Acad Dermatol 53:S59-69. 2005
..Because some degree of therapy will always be necessary, ranging from maintenance of long-term remission to control of acute psoriasis flares, each patient requires an individualized plan...
Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studiesMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
J Drugs Dermatol 6:428-35. 2007
..Calcitriol 3 microg/g ointment has demonstrated good clinical efficacy as well as topical and systemic safety when used to treat psoriasis...
Combining systemic retinoids with biologic agents for moderate to severe psoriasisElizabeth C A Smith
Department of Dermatology, Mount Sinai School of Medicine, New York, USA
Int J Dermatol 47:514-8. 2008
..Although numerous data exist regarding the use of acitretin and biologic agent therapy alone for psoriasis, little is known about the efficacy, safety, and tolerability of acitretin combined with biologic agents...
Review of therapy of psoriasis: the prebiologic armamentariumDavid S Aaronson
Mount Sinai School of Medicine, 5 East 98th Street, Box 1048, New York, NY 10029-6574, USA
Dermatol Clin 22:379-88, viii. 2004
..With the creation of the newer"biologics," however, the treatment of psoriasis is being re-evaluated...
Case studies in severe psoriasis: A clinical strategyMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, 1 Gustave Levy Place, Box 1047, New York, NY 10029-6574, USA
J Dermatolog Treat 14:26-46. 2003
..The purpose of the algorithms is to make optimum use of phototherapy, traditional cytotoxic and immunosuppressive agents, retinoids, and newer biologic agents...
The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasisMark Lebwohl
Mount Sinai School of Medicine, New York, New York, USA
Cutis 80:29-40. 2007
..It is notable that in subjects who were being treated with a variety of agents, the addition of clobetasol propionate spray 0.05% during the course of the study resulted in improvements in disease severity...
Treatment of psoriasis. Part 1. Topical therapy and phototherapyM Lebwohl
Department of Dermatology, The Mount Sinai School of Medicine of New York University, New York, NY 10029, USA
J Am Acad Dermatol 45:487-98; quiz 499-502. 2001
..Participants should also have a better understanding of side effects associated with each treatment, which should help in determining options for therapy...
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasisM Lebwohl
Mount Sinai Medical Center, New York, New York 10029, USA
J Am Acad Dermatol 38:705-11. 1998
..A new class of topical receptor-selective acetylenic retinoids, the first of which is tazarotene, has been developed...
DNA structural integrity and base composition affect ultraviolet light-induced oxidative DNA damageH Wei
Department of Dermatology, Mount Sinai Medical Center, Box 1047, New York, New York 10029, and Department of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
Biochemistry 37:6485-90. 1998
..These results suggest that the intercalation of genistein and estradiol into DNA may alter the DNA structural integrity, interrupt the production of oxidizing species, and subsequently reduce the formation of 8-OHdG by UV radiation...
Vitamin D and topical therapyMark Lebwohl
Department of Dermatology, The Mount Sinai School of Medicine, New York, New York, USA
Cutis 70:5-8. 2002
..05% ointment and cream have been shown to be compatible with calcipotriene for up to 2 weeks. The compatibility of calcipotriene and halobetasol permits the use of these agents together...
Retrospective analysis of the treatment of psoriasis of the palms and solesP I Spuls
Department of Dermatology, Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY 10029-6574, USA
J Dermatolog Treat 14:21-5. 2003
..Other biologic agents are likely to be added to this list in the future...
Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasisS Maryles
Department of Dermatology, Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY 10029-6574, USA
J Dermatolog Treat 14:7-16. 2003
..This article focuses on the transition for patients with psoriasis being managed with methotrexate and cyclosporine to retinoids, phototherapy, and newer agents...
Combination therapy with vitamin D analoguesS Lamba
Department of Dermatology, Mount Sinai Medical Center, New York 10029-6574, USA
Br J Dermatol 144:27-32. 2001
..As long as treatments are used correctly, the benefits of combination therapy with vitamin D analogues usually outweigh the few drawbacks...
Treatment of psoriasis. Part 2. Systemic therapiesM Lebwohl
Department of Dermatology, The Mount Sinai School of Medicine of New York University, One Gustave L Levy Place, New York, NY 10029, USA
J Am Acad Dermatol 45:649-61; quiz 662-4. 2001
..Combinations of different treatments are addressed and investigational therapies that are in development are reviewed...
Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trialM Lebwohl
Mount Sinai School of Medicine, New York, NY, U S A
Br J Dermatol 162:137-46. 2010
..Conclusions Ustekinumab improves HRQoL in patients with moderate-to-severe psoriasis. Patient-reported outcomes measured a treatment effect beyond that indicated by clinical measures...
Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasisM Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York University 10029-6574, USA
J Am Acad Dermatol 45:544-53. 2001
....
Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for useAmy S Paller
Department of Dermatology, Northwestern University s Feinberg Medical School Children s Memorial Hospital, 676 North St Clair St, Suite 1600, Chicago, IL 60611, USA
Pediatrics 122:e1210-8. 2008
....
The effect of weight on the efficacy of biologic therapy in patients with psoriasisLily Clark
Department of Dermatology at Columbia University, New York, New York, USA
J Am Acad Dermatol 58:443-6. 2008
..Patients with psoriasis, in particular, tend to be above normal weight. Three of the 5 biologics used to treat psoriasis are fixed-dosed treatments: alefacept, etanercept, and adalimumab. Dosing regimens do not account for weight...
Tacrolimus ointment is effective for facial and intertriginous psoriasisMark Lebwohl
Mt. Sinai School of Medicine, New York, New York, USA
J Am Acad Dermatol 51:723-30. 2004
..0001) based on a Static Severity Score. Adverse events were similar in the 0.1% tacrolimus ointment and vehicle groups. Conclusion Tacrolimus ointment is an effective treatment for psoriasis of the face or intertriginous areas...
Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized studyCarin Gribetz
Mt Sinai School of Medicine, Department of Dermatology, New York, New York, USA
J Am Acad Dermatol 51:731-8. 2004
..0007). Adverse events were similar between groups. CONCLUSION: Pimecrolimus cream 1% is an effective treatment for inverse psoriasis with a rapid onset of action, and is safe and well-tolerated...
Retrospective study of the efficacy of narrowband UVB and acitretinP I Spuls
Department of Dermatology, Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY 10029-6574, USA
J Dermatolog Treat 14:17-20. 2003
..CONCLUSION: The combination of acitretin with narrowband UVB results in faster improvement even in more difficult-to-treat patients. In combination the treatments appear to have synergistic effects...
Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in miceH Wei
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
Carcinogenesis 19:1509-14. 1998
..05). Our results suggest that genistein exerts its anti-initiational and anti-promotional effects on skin carcinogenesis probably through blockage of DNA adduct formation and inhibition of oxidative and inflammatory events in vivo...
Acitretin suppression of squamous cell carcinoma: case report and literature reviewM Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, 1 Gustave Levy Place, Box 1047, New York, NY 10029-6574, USA
J Dermatolog Treat 14:3-6. 2003
..Acitretin should be considered as a maintenance therapy for psoriasis patients developing squamous cell carcinomas as a result of PUVA therapy...
In vitro compatibility of tazarotene with other topical treatments of psoriasisD Hecker
Department of Dermatology, The Mount Sinai School of Medicine, New York, New York, USA
J Am Acad Dermatol 42:1008-11. 2000
..These results suggest that tazarotene gel can be successfully coprescribed with a range of commonly used topical psoriasis treatments without adversely affecting the chemical stability of either agent...
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatosesAnnemarie Uliasz
Department of Dermatology, Mount Sinai School of Medicine, New York, New York 10029, USA
Cutis 81:517-9. 2008
..05% caused a significantly greater reduction in epidermal thickness compared with fluocinonide cream 0.1% when used twice daily for 2 weeks (P<.001). However, neither drug caused significant clinical signs of atrophy...
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologicsAlice Gottlieb
Department of Dermatology, Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
J Am Acad Dermatol 58:851-64. 2008
..We will discuss the use of disease-modifying antirheumatic drugs and the biologic therapies in the treatment of patients with moderate to severe psoriatic arthritis...
Newly available treatments for psoriatic arthritis and their impact on skin psoriasisHassan Galadari
Department of Dermatology, Mt. Sinai Medical Center, New York, NY 10029, USA
Int J Dermatol 42:231-7. 2003
..TNF inhibitors represent new therapeutic options for patients with PsA. The potential advantages of treatment with etanercept and infliximab early in the disease course are discussed...
Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitisCharles N Ellis
Department of Dermatology, University of Michigan Medical School, Ann Arbor 48109-0314, USA
J Am Acad Dermatol 48:553-63. 2003
..CONCLUSION: In the base case analyses, tacrolimus ointment was more cost-effective than HPTCs administered in 2-week treatment cycles, and similar in cost-effectiveness to 4-week cycles of HPTCs...
Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part IDavid M Pariser
Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
J Cutan Med Surg 9:303-12. 2005
..Effective psoriasis therapies are needed for long-term symptom control...
Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literatureCaroline P Halverstam
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
J Cutan Med Surg 10:291-9. 2006
..Low-dose acitretin has been used for many years as monotherapy or in combination with other systemic therapies for psoriasis. Evidence to date suggests that the frequency of symptomatic bony effects is quite low in these patients...
Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivoH Wei
Department of Dermatology, The Mount Sinai Medical Center, New York, NY 10029, USA
Carcinogenesis 19:1013-8. 1998
..Our studies suggest that reduction of oxidative damages to biological macromolecules in vitro and in vivo may at least in part explain the anti-carcinogenic and chemopreventive actions of tamoxifen...
The use of alefacept in the treatment of psoriasisV K Wong
Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA
Skin Therapy Lett 8:1-2, 7. 2003
..These findings support the use of alefacept as a viable treatment of psoriasis, without the toxicities associated with some of the current systemic treatments available...
Actinic keratosis: epidemiology and progression to squamous cell carcinomaM Lebwohl
Mount Sinai School of Medicine, 5E 98 St, New York, NY 10029, USA
Br J Dermatol 149:31-3. 2003
..There is strong evidence that actinic keratoses can progress to squamous cell carcinoma, underscoring the need to identify and treat patients at risk...
Tacrolimus ointment in the treatment of eyelid dermatitisAmy Krupnick Freeman
Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA
Cutis 73:267-71. 2004
..In addition, none of the patients developed cataracts or glaucoma during the study. In summary, tacrolimus ointment 0.1% may be a safe and effective treatment option for patients with moderate to severe eyelid dermatitis...
A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasisMark Lebwohl
Departments of Dermatology, Mount Sinai Medical Center, New York, NY 10029 6574, USA
Int J Dermatol 41:269-74. 2002
..A clobetasol propionate foam product is as effective as clobetasol propionate solution in the treatment of scalp psoriasis...
Overview on desonide 0.05%: a clinical safety profileVicky Kwan Wong
Department of Dermatology, Mount Sinai Medical Center, New York, NY 10029 6574, USA
J Drugs Dermatol 3:393-7. 2004
..The excellent safety profile of desonide revealed by this pharmacovigilance program is supported by a review of published clinical trial results...
Potential complications associated with the use of biologic agents for psoriasisJoshua A Zeichner
Department of Dermatology, Mount Sinai Medical Center, 5 East 98th Street, Box 1048, New York, NY 10029, USA
Dermatol Clin 25:207-13, vii. 2007
..Both physicians and patients should be aware of the risks involved with each medicine so that the correct drug is chosen to suit each patient...
Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapiesCarin H Endzweig-Gribetz
Department of Dermatology, Mount Sinai School of Medicine, One Gustave Levy Place, New York, New York 10029, USA
J Cutan Med Surg 6:12-6. 2002
Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areasAmy Krupnick Freeman
Mount Sinai School of Medicine, Department of Dermatology, New York, NY 10029, USA
J Am Acad Dermatol 48:564-8. 2003
..In summary, tacrolimus 0.1% ointment may be a safe and effective treatment option for patients with psoriasis on the face, intertriginous areas, or both...
Prominent mental (chin) crease: a new sign of pseudoxanthoma elasticumMark Lebwohl
Department of Dermatology at the Mount Sinai School of Medicine, USA
J Am Acad Dermatol 48:620-2. 2003
..Mental creases commonly occur in patients with PXE. In young patients they are a sensitive and highly specific physical finding of this disorder. The presence of exaggerated mental creases is, thus, a useful physical marker for PXE...
PsoriasisMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
Lancet 361:1197-204. 2003
..Enhancements in topical therapy and phototherapy have also increased the armamentarium of treatments available for this disorder...
Pilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasisDanielle Levine
Department of Dermatology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
J Am Acad Dermatol 63:775-81. 2010
..By inhibiting proinflammatory cytokines such as interleukin-12, interleukin-23, and tumor necrosis factor-alfa, nicotinamide may enhance the efficacy of calcipotriene therapy when used in combination...
Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndromeMarvin J Rapaport
Department of Dermatology, UCLA School of Medicine, Los Angeles, California, USA
Clin Dermatol 21:201-14. 2003
Treatment of mycosis fungoides with oral bexarotene combined with PUVADana Kaslow Stern
Mount Sinai Medical Center, One Gustave L Place, New York, NY 10029, USA
J Drugs Dermatol 1:134-6. 2002
..Our patient's response to a novel regimen of low dose bexarotene combined with PUVA has been excellent and suggests that this regimen may be a useful method for treatment of MF...
Combination therapy to treat moderate to severe psoriasisMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, Mt Sinai Medical Center, 5 E 98th Street, 12th Floor, New York, NY 10029 6574, USA
J Am Acad Dermatol 50:416-30. 2004
....
Combining the new biologic agents with our current psoriasis armamentariumMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
J Am Acad Dermatol 49:S118-24. 2003
..Mechanisms of action of the biologic therapies suggest that there is potential for additive benefit when used in combination regimens...
A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomesJohn Koo
UCSF Psoriasis and Phototherapy Treatment Center, Department of Dermatology, University of California, San Francisco 94118, USA
J Am Acad Dermatol 55:637-41. 2006
..Weekday calcipotriene plus weekend pulse clobetasol foam shows a consistent trend toward greater maintenance of remission...
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership surveyG Krueger
Department of Dermatology, University of Utah Medical School, 50 N Medical Dr, Salt Lake City, UT 84132, USA
Arch Dermatol 137:280-4. 2001
..Physicians may need to improve communication with their patients and should reevaluate their management of psoriasis...
Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasisK Kuroda
Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA
J Invest Dermatol 116:713-20. 2001
....
Determination of desmosines in elastin-related skin disorders by isocratic high-performance liquid chromatographyE Schwartz
Department of Dermatology, Mount Sinai School of Medicine, New York, New York 10029
Exp Mol Pathol 52:63-8. 1990
..Furthermore, PXE and normal skin elastins had the same amount of desmosines per milligram purified elastin. This method could be used to evaluate the extent of elastosis or elastolysis in a particular lesion...
The penetration of 0.005% fluticasone propionate ointment in eyelid skinM H Tan
Department of Dermatology, The Mount Sinai School of Medicine of New York University, 5 E 98th St, New York, NY 10029, USA
J Am Acad Dermatol 45:392-6. 2001
..618% +/- 0.339% to 1.467% +/- 0.695%). CONCLUSION: Further studies are warranted to examine the safety and efficacy of 0.005% fluticasone propionate ointment for the treatment of eyelid dermatoses...
Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratosesJoshua A Zeichner
Mount Sinai Medical Center, New York, New York, USA
J Am Acad Dermatol 60:59-62. 2009
..Imiquimod 5% cream applied twice weekly for 16 weeks is effective for treating actinic keratoses but may be limited by local side effects...
Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trialSewon Kang
Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA
Am J Clin Dermatol 6:245-53. 2005
..0074). CONCLUSION: Long-term treatment with tretinoin emollient cream 0.05% is safe and effective in subjects with moderate to severe facial photodamage...
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus ConferenceRobert E Kalb
Department of Dermatology State University of New York at Buffalo, School of Medicine and Biomedical Science, Buffalo, New York, USA
J Am Acad Dermatol 60:824-37. 2009
..Methotrexate remains a valuable option for the treatment of psoriasis. This report will summarize studies regarding the use of methotrexate since the last guidelines were published in 1998...
Imiquimod cream in the treatment of actinic keratosesAndrea Persaud
Department of Dermatology, The Mount Sinai School of Medicine of New York University, New York, NY 1029, USA
J Am Acad Dermatol 47:S236-9. 2002
..Treatments were well tolerated. Imiquimod cream appears to be effective in the treatment of actinic keratoses. The main adverse effect is local inflammation, which can be avoided by reducing the frequency of application...
An extended 16-week course of alefacept in the treatment of chronic plaque psoriasisCarin H Gribetz
Department of Dermatology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA
J Am Acad Dermatol 53:73-5. 2005
..Extended dosing with alefacept appeared to have a similar safety profile to 12-week dosing and may offer further benefit to some patients for disease improvement...
Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genisteinHuachen Wei
Department of Dermatology, Box 1047, Mount Sinai School of Medicine, One Gustave Levy Place, 1425 Madison Avenue, New York, NY 10029, USA
Cancer Lett 185:21-9. 2002
..Thus, the antioxidative properties of genistein may explain for the mechanisms of anti-photocarcinogenic action of genistein...
Evaluation of sensory irritation caused by topical medications using a novel techniqueAnnemarie Uliasz
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
Int J Dermatol 49:269-71. 2010
..The aim of this study was to evaluate and compare the sensory irritation caused by hydrocortisone butyrate lipocream 0.1% using a non-invasive and inexpensive technique...
Protective effects of lycopene against ultraviolet B-induced photodamageZsuzsanna Fazekas
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
Nutr Cancer 47:181-7. 2003
....
Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesisJulian O Moore
Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA
Carcinogenesis 27:1627-35. 2006
..The implications of our findings serve as compelling validation to our conclusions that genistein may serve as a potent chemopreventive agent against photocarcinogenesis...
Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teasH Wei
Department of Dermatology, Mount Sinai NYU Medical Center, New York, NY 10029, USA
Free Radic Biol Med 26:1427-35. 1999
..The potent scavenging of oxygen species and blocking of UV-induced oxidative DNA damage may, at least in part, explain the mechanism(s) by which green/black teas inhibit photocarcinogenesis...
Recent advances in medical dermatologyLily N Clark
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
Int J Dermatol 46:1005-10. 2007
....
Mammographic findings in pseudoxanthoma elasticumLionel Bercovitch
Department of Dermatology, Rhode Island Hospital and Brown Medical School, Providence, USA
J Am Acad Dermatol 48:359-66. 2003
..The presence of both of these findings, especially with skin thickening or axillary skin calcification, should suggest a diagnosis of PXE. The majority of breast calcifications in PXE are benign...
Use and abuse of topical corticosteroids in infections of the skin and related structuresVicky Kwan Wong
Mount Sinai School of Medicine, 5 East 98th Street, 12th Floor, Box 1048, New York, NY 10029, USA
J Drugs Dermatol 2:268-76. 2003
....
A new standardized method of evaluating cutaneous irritation from topical medicationsAnnemarie Uliasz
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
Cutis 82:75-7. 2008
..05%, was calculated to be 2.55. Our assay was able to detect and quantify even minimal cutaneous irritation secondary to application of topical medications...
Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trialMark Lebwohl
Mount Sinai School of Medicine, New York, NY, USA
Int J Dermatol 43:17-20. 2004
..CONCLUSIONS: Ciclopirox shampoo 1% is effective and safe in the treatment of seborrheic dermatitis of the scalp...
The use of systemic immune moderators in dermatology: an updateDana Kazlow Stern
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA
Dermatol Clin 23:259-300. 2005
..This article reviews the pharmacology, mechanism of action, side effects, and clinical applications of these therapies...
Effects of the isoflavone 4',5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamageEileen Q Shyong
Department of Dermatology, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029, USA
Carcinogenesis 23:317-21. 2002
..005). These results indicate that genistein protects the skin from PUVA-induced photodamage...
Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea crurisM Lebwohl
Mount Sinai Medical Center, 5 E 98th St, 12th Floor, Box 1048, New York, NY 10029, USA
Cutis 67:261-6. 2001
..We conclude that one week of therapy with terbinafine 1% solution is highly effective, superior to vehicle, and safe for use in superficial fungal infections...
Clinical management of psoriasis: principles and practiceM Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA
Cutis 67:1-15. 2001
..The clinical uses of these agents are illustrated in part through case presentations drawn from the authors' practices, and the supportive role of the National Psoriasis Foundation is reviewed...
New cutaneous manifestations of systemic diseasesS D Khorenian
Mount Sinai Medical Center, New York, New York
Am Fam Physician 51:625-30. 1995
..Paraneoplastic pemphigus, a recently characterized autoimmune vesicular eruption, produces painful mucocutaneous ulcerations in patients with an occult neoplasm, such as chronic lymphocytic leukemia or malignant lymphoma...
Pseudoxanthoma elasticum: significance of limited phenotypic expression in parents of affected offspringD W Sherer
Department of Dermatology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA
J Am Acad Dermatol 44:534-7. 2001
..Therefore all first-degree relatives of affected patients should receive a full dermatologic examination as well as a funduscopic examination. If even mild typical skin or eye findings are present, then skin biopsy should be performed...
Acne therapy: clinical pearlsR H Stein
Department of Dermatology and Cutaneous Surgery, Mount Sinai Medical Center, New York, NY 10029-6574, USA
Semin Cutan Med Surg 20:184-9. 2001
....
Should we switch from combination UVA/UVB phototherapy units to narrowband UVB?Mark Lebwohl
Department of Dermatology, The Mount Sinai School of Medicine of NYU, 5 East 98th Street, Box 1048, New York, NY 10029 6574, USA
Photodermatol Photoimmunol Photomed 18:44-6; discussion 47-9. 2002
Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skinYongyin Wang
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
Int J Cancer 116:193-9. 2005
..G-->A mutations induced by BaP or BaP-UVA at position 38 of codon 13 have not been reported previously. C-->T transitions were detected in p53 hot spots of exon 8 in 2 of 19 BaP-UVA-induced tumors but were not found in nontumor skin...
Pseudoxanthoma elasticum: Temporary treatment of chin folds and lines with injectable collagenHassan Galadari
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
J Am Acad Dermatol 49:S265-6. 2003
..We report 2 patients with pseudoxanthoma elasticum who had characteristic rhytides and horizontal creases of the chin ("mental" creases). Rhytides and horizontal creases were successfully treated with injectable collagen...
The combination of benzo[a]pyrene and ultraviolet A causes an in vivo time-related accumulation of DNA damage in mouse skinRao Saladi
Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029, USA
Photochem Photobiol 77:413-9. 2003
..80). These results indicate that genetic damage caused by exposures to BaP plus UVA accumulates with time and increases the potential for inductive events leading to carcinogenesis and tumor formation...
Impaired skin barrier function in dermatologic disease and repair with moisturizationMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA
Cutis 76:7-12. 2005
....
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsAlan Menter
Baylor University Medical Center, Dallas, Texas, USA
J Am Acad Dermatol 58:826-50. 2008
..Finally, we will discuss the safety and efficacy of the biologic treatments used to treat patients with psoriasis...
Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasisAlice B Gottlieb
Clinical Research Center, UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ 08901 0019, USA
Clin Immunol 111:28-37. 2004
..Reduction in lesional, activated T cells induces improvement in psoriatic plaques. Galiximab (IDEC-114), an IgG(1) anti-CD80 antibody, binds to CD80, a costimulatory molecule involved in T-cell activation...
A novel targeted T-cell modulator, efalizumab, for plaque psoriasisMark Lebwohl
Mt. Sinai School of Medicine, New York 10029-6574, USA
N Engl J Med 349:2004-13. 2003
..CONCLUSIONS: Efalizumab therapy resulted in significant improvements in plaque psoriasis in subjects with moderate-to-severe disease. Extending treatment from 12 to 24 weeks resulted in both maintenance and improvement of responses...
Are patients with psoriasis undertreated? Results of National Psoriasis Foundation surveyElizabeth J Horn
National Psoriasis Foundation, Portland, Oregon 97223 7195, USA
J Am Acad Dermatol 57:957-62. 2007
..We sought to assess whether patients with psoriasis with moderate or severe disease are being treated with systemic therapy...
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasisGerald G Krueger
University of Utah, Salt Lake City, USA
N Engl J Med 356:580-92. 2007
..Skin-infiltrating lymphocytes expressing type 1 cytokines have been linked to the pathophysiology of psoriasis. We evaluated the safety and efficacy of a human interleukin-12/23 monoclonal antibody in treating psoriasis...
New developments in the treatment of psoriasisMark Lebwohl
Arch Dermatol 138:686-8. 2002
Potential future dermatological indications for tacrolimus ointmentThomas Ruzicka
Department of Dermatology, , Moorenstr 5, , Germsny
Eur J Dermatol 13:331-42. 2003
..It also provides recommendations for future clinical studies with tacrolimus ointment...
Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicleDebra Breneman
University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
J Am Acad Dermatol 58:990-9. 2008
..Intermittent dosing of a topical calcineurin inhibitor for preventing atopic dermatitis (AD) disease relapse in patients with stabilized AD has not been evaluated...
Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasisJean Paul Ortonne
hopital l Archet II, 15 Rue de Saint Antoine de Ginestiere, BP 079, Nice, France
Eur J Dermatol 13:117-23. 2003
..These results provide further support for the deleterious roles of CD4+ and CD8+ memory T-cell subpopulations in psoriasis pathogenesis...
The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasisAlan Menter
Baylor University Medical Center, Dallas, Texas, USA
J Am Acad Dermatol 54:61-3. 2006
..30 [1.26-4.19]). Alefacept provided incremental efficacy over 5 successive 12-week treatment courses...
Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibodyAlice B Gottlieb
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
J Am Acad Dermatol 47:692-700. 2002
..The serum half-life of IDEC-114 was approximately 13 days. A single dose of IDEC-114 appears to be safe and well tolerated and has promising clinical activity in psoriasis...